๐๏ธ Verified NIH Record โข Updated 2026-05-04
MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases (NCT04246879)
Diagnostic Accuracy of Delayed MRI Contrast Enhancement Characteristics and Radiation Necrosis Following Stereotactic Radiosurgery (SRS) for Brain Metastases
๐ต Active, Not Recruiting Observational / Diagnostic ๐ Clinical Research Protocol Sponsor: Duke University
๐ฉบ Plain-English Summary (8th-Grade Level)
The purpose of this study is to test whether an additional magnetic resonance image (MRI) sequence can improve the ability to distinguish radiation damage from tumor recurrence in participants with brain metastasis who have previously been treated with stereotactic radiosurgery (SRS).
Who can join: Review the eligibility criteria below.
Location: Duke University Health System โ Durham, North Carolina
Age range: 18 Years
๐งช Interventions in This Study
- MRI (OTHER)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Duke University Health System โ Durham, North Carolina
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Brain Metastases
- Preop fSRS for Resectable Brain Metastases โ Tampa, Florida
- Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases โ Washington D.C., District of Columbia
- Study Assessing QBS72S For Treating Brain Metastases โ Palo Alto, California
- A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy โ Houston, Texas
- Neurocognitive Decline in Patients With Brain Metastases โ Dallas, Texas
Explore by condition: All Brain Metastases clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.